Regulatory Briefs: Contact Lenses; Circ Panel; Wheelchair Reclassification
This article was originally published in The Gray Sheet
Executive Summary
FDA has scheduled its ophthalmic panel to discuss expectations for contact lenses and accessories next month. Also, its circulatory devices panel will consider extracorporeal membrane oxygenation classification, and other devices. Finally, FDA has formally classified stair-climbing wheelchairs as class II with special controls.
You may also be interested in...
FDA Panel Supports Class II Status For Oxygenation Circuit Devices, And Two Other Categories
The Circulatory System Devices Panel supported class II, with special controls, reclassification proposals from FDA for extracorporeal membrane oxygenators; external cardiac compressors; and external pacemaker pulse generators and triple chamber pacing system analyzers. But the panel had some additional requests for further action by the agency.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.